Secondary non-response due to development of neutralising antibodies to botulinum toxin A during treatment of children with cerebral palsy

Neuropediatrics. 2000 Dec;31(6):333-4. doi: 10.1055/s-2000-12955.
No abstract available

Publication types

  • Clinical Trial
  • Controlled Clinical Trial
  • Letter

MeSH terms

  • Adolescent
  • Antibody Formation
  • Botulinum Toxins, Type A / immunology*
  • Botulinum Toxins, Type A / pharmacology*
  • Cerebral Palsy / drug therapy*
  • Child
  • Child, Preschool
  • Drug Resistance
  • Female
  • Humans
  • Injections, Intramuscular
  • Male
  • Neuromuscular Agents / immunology*
  • Neuromuscular Agents / pharmacology*

Substances

  • Neuromuscular Agents
  • Botulinum Toxins, Type A